For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Alzheimer's disease (AD) is a progressive degenerative neurological degenerative disease. Clinically, it is characterized by memory impairment, aphasia, misuse, loss of recognition, visual spatial impairment, executive dysfunction, and personality and behavioral changes such as personality dementia.
The Alzheimer's Therapeutics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Alzheimer's Therapeutics industry, and breaks down according to the type, application, and consumption area of Alzheimer's Therapeutics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Alzheimer's Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Alzheimer's Therapeutics market covered in Chapter 11:
Eisai Co. Ltd
Alector LLC
GE Healthcare
Cognition Therapeutics Inc.
Accera
Roche Holding AG
Eli Lilly and Company
TauRx
Neuro-Bio Ltd
Biogen Inc.
Novartis AG
Johnson & Johnson
Treventis Corporation
In Chapter 3, on the basis of types, the Alzheimer's Therapeutics market from 2018 to 2028 is primarily split into:
Cholinesterase Inhibitors
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Others
In Chapter 4, on the basis of applications, the Alzheimer's Therapeutics market from 2018 to 2028 covers:
Hospital Pharmacy
Retail Pharmacy
Online Sales
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028